Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Dorsey Wright & Associates. Point and Figure -- Ignore unavailable to you. Want to Upgrade?

To: PuddleGlum who wrote (3902)	12/31/1999 7:51:00 AM
From: Tommy Dorsey	Respond to of 9427

Puddle, your Bios might have been red yesterday but you have done well with your picks. I looked at the charts and they look fine. They could stand more pullback however on some. I forwarded your message to Sue for here answer. GT was put on CNBC only as a tax bounce candidate because it looks so terrible and is probably sold out. After two weeks if it hasn't moved, it's out. T

To: PuddleGlum who wrote (3902)	12/31/1999 9:08:00 AM
From: Susan Morrison	Read Replies (1) \| Respond to of 9427

Dear PuddleGlum, I did a feature on the biotech stocks a couple of weeks ago and recommended a handful of stocks, especially those related to the gene mapping subject. Those that were recommended included AFFX, CRA, MLNM, INCY and a couple of others. They have since run away (higher) and now need to see some type of consolidation; but I would watch for buying opportunities there. As well, we have AMGN on our Best Page, and have been recommending it since the mid 40's. It too is extended now, but one I would buy on a pullback or after some type of consolidation. The RS for the sector remains strong and I think this will be a sector to focus on in 2000. Regards, Susan Morrison Dorsey, Wright